Skip to main content
Premium Trial:

Request an Annual Quote

Hutch to Use GenoLogics' Informatics Suite in Early Cancer Detection Studies

NEW YORK (GenomeWeb News) – The Fred Hutchinson Cancer Research Center will use GenoLogics’ translational research software in its early-detection cancer research programs, the Canadian company said today.
 
The Canary Foundation, a non-profit charity focused on funding cancer detection research, is providing the center with GenoLogics' Biomedical Informatics software suite.
 
The software includes five products: BioVault is used to manage biospecimens; BioChronicle is used for managing clinical annotations; BioQuest is designed to enable web access; BioSphere is used to manage studies; and BioSource is used to enable electronic patient questionnaires.
 
The company said it will collaborate with Hutch to develop an integrated biorepository and biomedical informatics solution to be used in the center’s Translational and Outcomes Research group.
 
Financial terms of the agreement were not released.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.